Abstract
P-glycoprotein has a widespread expression on normal tissues. The protein has also been strongly associated with the multidrug resistance phenotype (MDR) on tumor cells. The employment of flow cytometry and confocal microscopy has contributed to the discovery and application of new particular fluorescent dyes. Nevertheless, several studies are being performed in different cellular types neglecting the expression activity of MDR proteins. Because many fluorochromes have been reported as P-glycoprotein substrates, an especial attention must be given to the properties of new dyes in the presence of MDR proteins. Flow cytometric analyzes of Mitotracker Green (MTG) fluorescence profile were performed in a human erythroleukemic cell line and its resistant counterpart. In this report we demonstrated that MTG, a probe used to evaluate the mitochondrial mass, is a P-glycoprotein substrate and its staining profile is dependent on the activity of this protein. In vitro studies on a human erythroleukemic cell line and its resistant counterpart revealed that MDR modulators (Cyclosporin A, Verapamil, and Trifluoperazine) alter the MTG fluorescence pattern on a resistant cell line. The findings suggest that attention should be given to the expression of P-glycoprotein when performing an evaluation of mitochondria properties with MTG.
Similar content being viewed by others
REFERENCES
Arboix, M., Paz, O. G., Colombo, T., and D'Incalci, M. (1997) Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis. J. Pharmacol. Exp. Ther. 281:1226–1230.
Bernardi, P., Petronilli, V., Di Lisa, F. and Forte, M. (2001) A mitochondrial perspective on cell death. Trends Biochem. Sci. 26:112-117.
Buckman, J. F., Hernandez, H., Kress, G. J., Votyakova, T. V., Pal, S., and Reynolds, I. J. (2001) MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial mem-brane potential and oxidants. J. Neurosci. Methods. 104:165-176.
Colombo, T., Zucchetti, M., and D'Incalci, M. (1994) Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. J. Pharmacol. Exp. Ther. 269:22-27.
de La Monte, S. M., Luong, T., Neely, T. R., Robinson, D., and Wands, J. R. (2001) Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Alcohol Clin. Exp. Res. 25:898-906.
Denecke, J., Fiedler, K., Hacker-Klom, U., Molenkamp, G., Jurgens, H., and Wolff, J. E. (1997) Mul-tiple drug-resistant C6 glioma cells cross-resistant to irradiation. Anticancer Res. 17:4531-4534.
Diaz, G. et al. (2001) Intra-and intercellular distribution of mitochondrial probes and changes after treatment with MDR modulators. IUBMB Life 51: 121-126.
Ford, J. M. and Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:155-199.
Garner, D. L., Thomas, C. A., Joerg, H. W., DeJarnette, J. M., and Marshall, C. E. (1997) Fluorometric assessments of mitochondrial function and viability in cryopreserved bovine spermatozoa. Biol. Reprod. 57:1401-1406.
Gottesman, M. M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 62:385-427.
Gottesman, M. M., Hrycyna, C. A., Schoenlein, P. V., Germann, U.A., and Pastan, I. (1995) Genetic analyzis of the multidrug transporter. Ann. Rev. Genet. 29:607-649.
Gottesman, M. M. and Ambudkar, S. V. (2001) Overview: ABC transporters and human disease. J. Bioenerg. Biomembr. 33:453-458.
Haugland, R. P. (2002) Probes for organelles. In: Handbook of Fluorescent Probes and Research Products, Molecular Probes, Inc. Eugene, Oregon, pp. 473-488.
Juliano, R. L. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455:152-162.
Keij., J. F., Bell-Prince, C., and Steinkamp, J. A. (2000) Staining of mitochondrial membranes with 10-nonyl-acridine orange, MitoFluor Green, and MitoTracker Green is affected by mitochondrial mem-brane potential altering drugs. Cytometry 39:203-210.
Kessel, D., Beck, W. T., Kukuruga, D., and Schulz, V. (1991) Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51:4665-4670.
Kuhnel, J. M., Perrot, J. Y., Faussat, A. M., Marie, J. P., and Schwaller, M.A. (1997) Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia 11:1147-1155.
Maftah, A., Petit, J. M., Ratinaud, M. H., and Julien, R. (1989) 10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem. Biophys. Res. Com-mun. 164:185-190.
Marques-Santos, L. F., Bernardo, R. R., de Paula, E. F., and Rumjanek, V. M. (1999a) Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice. Pharmacol. Toxicol. 84:125-129.
Marques-Santos, L. F., Harab, R. C., de Paula, E. F., and Rumjanek, V. M. (1999b) The in ûiûo effect of the administration of resistance-modulating agents on rhodamine 123 distribution in mice thymus and lymph nodes. Cancer Lett. 137: 99-106.
Martel, J., Payet, M. D., and Dupuis, G. (1997) The MDR1 (P-glycoprotein) and MRP (P-190) trans-porters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes. Leuk. Res. 21:1077-1086.
Minderman, H. et al. (1996) DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Cytometry 25:14-20.
Neyfakh, A. A. (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell. Res. 174:168-176.
Petriz, J., O'Connor, J. E., and Garcia-Lopez, J. (1996) Rhodamine 123 efflux in drug resistance assays. Leukemia 10:748-749.
Poot, M. and Pierce, R. C. (1999) Detection of apoptosis and changes in mitochondrial membrane potential with chloromethyl-X-rosamine. Cytometry 36:359-360.
Rumjanek, V. M. et al. (2001) Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1. An. Acad. Bras. Cienc. 73:57-69.
Rumjanek, V. M., Lucena, M., Campos, M.M., Marques-Silva, V. M., and Maia, R. C. (1994) Multidrug resistance in leukemia: the problem and some approaches to its circumvention. Ciencia Cult. 46:63-69.
Schinkel, A. H. et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
Shapiro, H. M. (2000) Membrane potential estimation by flow cytometry. Methods 21:271-279.
Sun, Q. Y. et al. (2201) Translocation of active mitochondria during pig oocyte maturation, fertilization and early embryo development in vitro. Reproduction 122:155-163.
Sweet, S. and Singh, G. (1999) Changes in mitochondrial mass, membrane potential, and cellular adenos-ine triphosphate content during the cell cycle of human leukemic (HL-60) cells. J. Cell. Physiol. 180:91-96.
Vizler, C., Nagy, T., Kusz, E., Glavinas, H., and Duda, E. (2002) Flow cytometric cytotoxicity assay for measuring mammalian and avian NK cell activity. Cytometry 47:158-162.
Rights and permissions
About this article
Cite this article
Marques-Santos, L.F., Oliveira, J.G.P., Maia, R.C. et al. Mitotracker Green Is a P-Glycoprotein Substrate. Biosci Rep 23, 199–212 (2003). https://doi.org/10.1023/B:BIRE.0000007693.33521.18
Issue Date:
DOI: https://doi.org/10.1023/B:BIRE.0000007693.33521.18